OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Expression of MUC1 in different tumours and its clinical significance (Review)
Yue Lan, Weihua Ni, Guixiang Tai
Molecular and Clinical Oncology (2022) Vol. 17, Iss. 6
Open Access | Times Cited: 32
Yue Lan, Weihua Ni, Guixiang Tai
Molecular and Clinical Oncology (2022) Vol. 17, Iss. 6
Open Access | Times Cited: 32
Showing 1-25 of 32 citing articles:
The Role of MUC1 in Renal Cell Carcinoma
Martina Milella, Monica Rutigliano, Francesco Lasorsa, et al.
Biomolecules (2024) Vol. 14, Iss. 3, pp. 315-315
Open Access | Times Cited: 34
Martina Milella, Monica Rutigliano, Francesco Lasorsa, et al.
Biomolecules (2024) Vol. 14, Iss. 3, pp. 315-315
Open Access | Times Cited: 34
Immunoengineering can overcome the glycocalyx armour of cancer cells
Sangwoo Park, Marshall J. Colville, Justin H. Paek, et al.
Nature Materials (2024) Vol. 23, Iss. 3, pp. 429-438
Open Access | Times Cited: 13
Sangwoo Park, Marshall J. Colville, Justin H. Paek, et al.
Nature Materials (2024) Vol. 23, Iss. 3, pp. 429-438
Open Access | Times Cited: 13
Targeted Tumor Delivery Using Extracellular Vesicles
Hema Saranya Ilamathi, Samir EL Andaloussi, Oscar P. B. Wiklander
Methods in pharmacology and toxicology (2025), pp. 125-153
Closed Access | Times Cited: 1
Hema Saranya Ilamathi, Samir EL Andaloussi, Oscar P. B. Wiklander
Methods in pharmacology and toxicology (2025), pp. 125-153
Closed Access | Times Cited: 1
A quantitative spatial cell-cell colocalizations framework enabling comparisons between in vitro assembloids and pathological specimens
Gina Bouchard, Weiruo Zhang, Ilayda Ilerten, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 1
Gina Bouchard, Weiruo Zhang, Ilayda Ilerten, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 1
Adoptive Cell Therapy in Hepatocellular Carcinoma: A Review of Clinical Trials
Muhammet Özer, Suleyman Yasin Goksu, Baran Akagündüz, et al.
Cancers (2023) Vol. 15, Iss. 6, pp. 1808-1808
Open Access | Times Cited: 17
Muhammet Özer, Suleyman Yasin Goksu, Baran Akagündüz, et al.
Cancers (2023) Vol. 15, Iss. 6, pp. 1808-1808
Open Access | Times Cited: 17
Intrahepatic cholangiocarcinoma biomarkers: Towards early detection and personalized pharmacological treatments
Maurizio Capuozzo, Mariachiara Santorsola, Francesco Ferrara, et al.
Molecular and Cellular Probes (2024) Vol. 73, pp. 101951-101951
Open Access | Times Cited: 8
Maurizio Capuozzo, Mariachiara Santorsola, Francesco Ferrara, et al.
Molecular and Cellular Probes (2024) Vol. 73, pp. 101951-101951
Open Access | Times Cited: 8
Tandem CAR-T cells targeting MUC1 and PSCA combined with anti-PD-1 antibody exhibit potent preclinical activity against non-small cell lung cancer
Aying Wang, Tangfeng Lv, Yong Song
Cellular Immunology (2023) Vol. 391-392, pp. 104760-104760
Closed Access | Times Cited: 14
Aying Wang, Tangfeng Lv, Yong Song
Cellular Immunology (2023) Vol. 391-392, pp. 104760-104760
Closed Access | Times Cited: 14
Aptamers as Potential Therapeutic Tools for Ovarian Cancer: Advancements and Challenges
Wojciech Szymanowski, A. Szymanowska, Anna Bielawska, et al.
Cancers (2023) Vol. 15, Iss. 21, pp. 5300-5300
Open Access | Times Cited: 12
Wojciech Szymanowski, A. Szymanowska, Anna Bielawska, et al.
Cancers (2023) Vol. 15, Iss. 21, pp. 5300-5300
Open Access | Times Cited: 12
Dual Approaches in Oncology: The Promise of siRNA and Chemotherapy Combinations in Cancer Therapies
Carolina Sousa, Mafalda Videira
Onco (2025) Vol. 5, Iss. 1, pp. 2-2
Open Access
Carolina Sousa, Mafalda Videira
Onco (2025) Vol. 5, Iss. 1, pp. 2-2
Open Access
Adoptive cell therapies in thoracic malignancies: a comprehensive review
Yago Garitaonaindía, M. Martínez‐Cutillas, Maria Uribarren, et al.
Clinical & Translational Oncology (2025)
Closed Access
Yago Garitaonaindía, M. Martínez‐Cutillas, Maria Uribarren, et al.
Clinical & Translational Oncology (2025)
Closed Access
Potential Application of Circulating Tumor Cell Markers to Evaluate Response to Chemotherapy in Breast Cancer Patients: A Narrative Review
I Gusti Ngurah Gunawan Wibisana
Proceedings Book of The International Conference and Exhibition on The Indonesian Medical Education Research Institute. (2025) Vol. 8, Iss. -, pp. 130-141
Closed Access
I Gusti Ngurah Gunawan Wibisana
Proceedings Book of The International Conference and Exhibition on The Indonesian Medical Education Research Institute. (2025) Vol. 8, Iss. -, pp. 130-141
Closed Access
Inducible re-epithelialization of cancer cells increases autophagy and DNA damage: implications for breast cancer dormancy
Diana Drago-García, Suvendu Giri, Rishita Chattaerjee, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access
Diana Drago-García, Suvendu Giri, Rishita Chattaerjee, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access
CAR T Cells in Lung Cancer: Targeting Tumor-Associated Antigens to Revolutionize Immunotherapy
Sattam Khulaif Alenezi
Pathology - Research and Practice (2025), pp. 155947-155947
Closed Access
Sattam Khulaif Alenezi
Pathology - Research and Practice (2025), pp. 155947-155947
Closed Access
Re-epithelialization of cancer cells increases autophagy and DNA damage: Implications for breast cancer dormancy and relapse
Diana Drago-García, Suvendu Giri, Rishita Chatterjee, et al.
Science Signaling (2025) Vol. 18, Iss. 883
Closed Access
Diana Drago-García, Suvendu Giri, Rishita Chatterjee, et al.
Science Signaling (2025) Vol. 18, Iss. 883
Closed Access
Targeting Siglec–Sialylated MUC1 Immune Axis in Cancer
Ramya Ayyalasomayajula, Mare Čudić
Cancers (2024) Vol. 16, Iss. 7, pp. 1334-1334
Open Access | Times Cited: 3
Ramya Ayyalasomayajula, Mare Čudić
Cancers (2024) Vol. 16, Iss. 7, pp. 1334-1334
Open Access | Times Cited: 3
Biomarkers in high grade serous ovarian cancer
Mark C. Bates, Bashir M. Mohamed, F. Park Lewis, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024), pp. 189224-189224
Closed Access | Times Cited: 3
Mark C. Bates, Bashir M. Mohamed, F. Park Lewis, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024), pp. 189224-189224
Closed Access | Times Cited: 3
MUC1 promotes cancer stemness and predicts poor prognosis in osteosarcoma
Jian Liu, Yixi Xu, Tianqi Xu, et al.
Pathology - Research and Practice (2023) Vol. 242, pp. 154329-154329
Closed Access | Times Cited: 7
Jian Liu, Yixi Xu, Tianqi Xu, et al.
Pathology - Research and Practice (2023) Vol. 242, pp. 154329-154329
Closed Access | Times Cited: 7
Overcoming effector T cell exhaustion in ovarian cancer ascites with a novel adenovirus encoding for a MUC1 bispecific antibody engager and IL-2 cytokine
Saru Basnet, Mirte Van der Heijden, Dafne C.A. Quixabeira, et al.
Molecular Therapy (2024) Vol. 32, Iss. 9, pp. 3114-3127
Open Access | Times Cited: 2
Saru Basnet, Mirte Van der Heijden, Dafne C.A. Quixabeira, et al.
Molecular Therapy (2024) Vol. 32, Iss. 9, pp. 3114-3127
Open Access | Times Cited: 2
The Formation of Stable Lung Tumor Spheroids during Random Positioning Involves Increased Estrogen Sensitivity
Balkis Barkia, Viviann Sandt, Daniela Melnik, et al.
Biomolecules (2024) Vol. 14, Iss. 10, pp. 1292-1292
Open Access | Times Cited: 2
Balkis Barkia, Viviann Sandt, Daniela Melnik, et al.
Biomolecules (2024) Vol. 14, Iss. 10, pp. 1292-1292
Open Access | Times Cited: 2
Integrative big transcriptomics data analysis implicates crucial role of MUC13 in pancreatic cancer
Anupam Dhasmana, Swati Dhasmana, Shivangi Agarwal, et al.
Computational and Structural Biotechnology Journal (2023) Vol. 21, pp. 2845-2857
Open Access | Times Cited: 4
Anupam Dhasmana, Swati Dhasmana, Shivangi Agarwal, et al.
Computational and Structural Biotechnology Journal (2023) Vol. 21, pp. 2845-2857
Open Access | Times Cited: 4
Clinical significance of KL-6 in immune-checkpoint inhibitor treatment for non-small cell lung cancer
Kenji Nakahama, Motohiro Izumi, Naoki Yoshimoto, et al.
Cancer Chemotherapy and Pharmacology (2023) Vol. 92, Iss. 5, pp. 381-390
Closed Access | Times Cited: 4
Kenji Nakahama, Motohiro Izumi, Naoki Yoshimoto, et al.
Cancer Chemotherapy and Pharmacology (2023) Vol. 92, Iss. 5, pp. 381-390
Closed Access | Times Cited: 4
An oncolytic adenovirus co-expressing a bi-specific T cell engager and IL-2 for the treatment of ovarian cancer
Kalkidan Ayele, Hiroaki Wakimoto, Dipongkor Saha
Molecular Therapy (2024) Vol. 32, Iss. 9, pp. 2810-2813
Closed Access | Times Cited: 1
Kalkidan Ayele, Hiroaki Wakimoto, Dipongkor Saha
Molecular Therapy (2024) Vol. 32, Iss. 9, pp. 2810-2813
Closed Access | Times Cited: 1
Tn antigen interactions of macrophage galactose-type lectin (MGL) in immune function and disease
Berna Tumoglu, Aidan P. Keelaghan, Fikri Y. Avci
Glycobiology (2023) Vol. 33, Iss. 11, pp. 879-887
Closed Access | Times Cited: 2
Berna Tumoglu, Aidan P. Keelaghan, Fikri Y. Avci
Glycobiology (2023) Vol. 33, Iss. 11, pp. 879-887
Closed Access | Times Cited: 2
Preventative Cancer Vaccine-Elicited Human Anti-MUC1 Antibodies Have Multiple Effector Functions
Michelle L. McKeague, Jason Lohmueller, Matthew T. Dracz, et al.
Antibodies (2024) Vol. 13, Iss. 4, pp. 85-85
Open Access
Michelle L. McKeague, Jason Lohmueller, Matthew T. Dracz, et al.
Antibodies (2024) Vol. 13, Iss. 4, pp. 85-85
Open Access
Progress in the Study of Abnormal Expression of Mucin in Gastric Mucosal Lesions
晓慧 秦
Advances in Clinical Medicine (2024) Vol. 14, Iss. 11, pp. 746-753
Closed Access
晓慧 秦
Advances in Clinical Medicine (2024) Vol. 14, Iss. 11, pp. 746-753
Closed Access
